Search Results
Search for other papers by F. Cecoli in
Google Scholar
PubMed
Search for other papers by E.M. Ceresola in
Google Scholar
PubMed
Search for other papers by V. Altrinetti in
Google Scholar
PubMed
Search for other papers by M. Cabria in
Google Scholar
PubMed
Search for other papers by M. Cappagli in
Google Scholar
PubMed
Search for other papers by A. Montepagani in
Google Scholar
PubMed
Search for other papers by C.M. Cuttica in
Google Scholar
PubMed
Search for other papers by U. Filippi in
Google Scholar
PubMed
Search for other papers by D. Saverino in
Google Scholar
PubMed
Search for other papers by M. Raffa in
Google Scholar
PubMed
Search for other papers by M. Caputo in
Google Scholar
PubMed
Search for other papers by F. Minuto in
Google Scholar
PubMed
Search for other papers by M. Giusti in
Google Scholar
PubMed
Search for other papers by M. Bagnasco in
Google Scholar
PubMed
14 Sugitani I, Fujimoto Y: Management of low-risk papillary thyroid carcinoma: unique conventional policy in Japan and our efforts to improve the level of evidence. Surg Today 2010;40:199-215. 10.1007/s00595-009-4034-5 20180072 15 Sugitani I
Department of Otorhinolaryngology-Head and Neck Surgery, Chungnam National University Sejong Hospital, Sejong, Republic of Korea
Search for other papers by Ho-Ryun Won in
Google Scholar
PubMed
Search for other papers by Min Gyu Kim in
Google Scholar
PubMed
Search for other papers by Min Soo Kim in
Google Scholar
PubMed
Department of Otolaryngology-Head and Neck Surgery, Chungnam National University Hospital, Daejeon, Republic of Korea
Search for other papers by Jae Won Chang in
Google Scholar
PubMed
Department of Otolaryngology-Head and Neck Surgery, Chungnam National University Hospital, Daejeon, Republic of Korea
Search for other papers by Bon Seok Koo in
Google Scholar
PubMed
among all cancers ( 1 ). The majority of thyroid cancers are differentiated thyroid carcinoma, the most common form of which is papillary thyroid carcinoma ( 2 , 3 ). Since the 1980s, thyroid cancer, particularly papillary thyroid cancer, has been
Search for other papers by Irini S. Hadjisavva in
Google Scholar
PubMed
Search for other papers by Roberto Dina in
Google Scholar
PubMed
Search for other papers by Michael A. Talias in
Google Scholar
PubMed
Search for other papers by Panayiotis A. Economides in
Google Scholar
PubMed
estimated mortality rate of 5,993 patients each year [ 12 ]. Studies have shown a true rise in the incidence of micro and larger forms of papillary thyroid carcinoma in northwestern Spain, a higher incidence of thyroid cancer in the volcanic area of Sicily
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China
Search for other papers by Junyu Tong in
Google Scholar
PubMed
Department of Nuclear Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China
Search for other papers by Maomei Ruan in
Google Scholar
PubMed
Search for other papers by Yuchen Jin in
Google Scholar
PubMed
Search for other papers by Hao Fu in
Google Scholar
PubMed
Search for other papers by Lin Cheng in
Google Scholar
PubMed
Search for other papers by Qiong Luo in
Google Scholar
PubMed
Department of Pathology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China
Search for other papers by Zhiyan Liu in
Google Scholar
PubMed
Search for other papers by Zhongwei Lv in
Google Scholar
PubMed
Search for other papers by Libo Chen in
Google Scholar
PubMed
Introduction The incidence of thyroid cancer, the most common endocrine malignancy, has been increasing over the past decades. More than 87% of thyroid cancers are distinguished as differentiated thyroid carcinoma (DTC), including papillary
Department of Surgery, County Hospital Ryhov, Jönköping, Sweden
Search for other papers by Johannes Järhult in
Google Scholar
PubMed
Search for other papers by Ramtin Vedad in
Google Scholar
PubMed
malignancy (of whom 5 had carcinomas). Six patients had thyroid surgery due to thyrotoxicosis. Table 2 Main indication for thyroid surgery at re-referral in 102 patients with benign non-toxic goitre managed with expectancy at first visit
Search for other papers by Hyunju Park in
Google Scholar
PubMed
Search for other papers by Jung Heo in
Google Scholar
PubMed
Search for other papers by Hyun Jin Ryu in
Google Scholar
PubMed
Search for other papers by Min-Ji Kim in
Google Scholar
PubMed
Search for other papers by Young Lyun Oh in
Google Scholar
PubMed
Search for other papers by Tae Hyuk Kim in
Google Scholar
PubMed
Search for other papers by Sun Wook Kim in
Google Scholar
PubMed
Search for other papers by Jae Hoon Chung in
Google Scholar
PubMed
. Additionally, the prevalence of the BRAFV600E mutation in papillary thyroid carcinoma (PTC) ranges from 30% to greater than 80% ( 16 , 17 ), varying by geographic region and dietary components such as iodine intake ( 18 ). Thus, we conducted this study to
Search for other papers by Chitra Choudhary in
Google Scholar
PubMed
Search for other papers by Leonard Wartofsky in
Google Scholar
PubMed
Search for other papers by Eshetu Tefera in
Google Scholar
PubMed
Search for other papers by Kenneth D. Burman in
Google Scholar
PubMed
clinically significant structural progression. Thyroid 2011;21:845-853. 10.1089/thy.2011.0011 21809914 7 Grant CS, Hay ID, Gough IR, Bergstralh EJ, Goellner JR, McConahey WM: Local recurrence in papillary thyroid carcinoma: is extent of surgical
Department of Genetics and Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
Search for other papers by Mohammad-Reza Mahmoudian-sani in
Google Scholar
PubMed
Search for other papers by Ameneh Mehri-Ghahfarrokhi in
Google Scholar
PubMed
Search for other papers by Majid Asadi-Samani in
Google Scholar
PubMed
Search for other papers by Gholam-Reza Mobini in
Google Scholar
PubMed
are involved in apoptosis and cell cycle regulation. Targeting this subset of miRNAs can be useful in thyroid papillary carcinoma diagnosis and treatment management [ 28 ]. miRNA-375 Two separate studies examined the expression status of miRNA
Search for other papers by Min Ji Jeon in
Google Scholar
PubMed
Search for other papers by Won Gu Kim in
Google Scholar
PubMed
Search for other papers by Ki-Wook Chung in
Google Scholar
PubMed
Search for other papers by Jung Hwan Baek in
Google Scholar
PubMed
Search for other papers by Won Bae Kim in
Google Scholar
PubMed
Search for other papers by Young Kee Shong in
Google Scholar
PubMed
carcinomas (PTCs) including papillary thyroid microcarcinomas (PTMCs) [ 1 , 2 ]. For the last several decades, we did not have sufficient knowledge of the biological behavior of PTMCs, and were surprised to find that many of these PTMCs have similar
Search for other papers by Mario Monaco in
Google Scholar
PubMed
Search for other papers by Gennaro Chiappetta in
Google Scholar
PubMed
Search for other papers by Concetta Aiello in
Google Scholar
PubMed
Search for other papers by Antonella Federico in
Google Scholar
PubMed
Search for other papers by Romina Sepe in
Google Scholar
PubMed
Search for other papers by Daniela Russo in
Google Scholar
PubMed
Instituto Nacional de Câncer - INCA, Rio de Janeiro, Brazil
Search for other papers by Alfredo Fusco in
Google Scholar
PubMed
Search for other papers by Pierlorenzo Pallante in
Google Scholar
PubMed
thyroid neoplasias [ 4 ]. Indeed, its expression is slightly reduced in papillary and follicular carcinomas compared to normal thyroid tissues, whereas its expression is not detected at all in anaplastic thyroid carcinomas. Re-expression of CBX7 in thyroid